Research Use Only - Not for human consumption. 18+ only.
Clinical TrialsCosmetic & TopicalTopical

Matrixyl

Also known as: Palmitoyl Pentapeptide-4, Pal-KTTKS

Palmitoyl Pentapeptide-4, a signal peptide that stimulates collagen and fibronectin production. One of the most well-studied cosmetic peptides for anti-aging skincare. Acts as a fragment of collagen I that signals fibroblasts to increase extracellular matrix synthesis.

Research Status

Clinical Trials

Moderate Clinical Data

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Increases collagen I and III production
Improves skin firmness and elasticity
Reduces fine lines and wrinkles
Enhances skin hydration and texture
Strengthens dermal matrix structure
Supports skin barrier function
Promotes fibroblast activity

Side Effects

Mild skin irritation or redness
UncommonMild

May occur in sensitive individuals during the first few days of use. Typically resolves with continued use as skin acclimates. If irritation persists, reduce frequency to 1x daily or discontinue use.

Transient tingling or slight stinging
UncommonMild

Some users report mild tingling upon application, particularly if applied to freshly cleansed skin. This is generally self-resolving and does not indicate harm.

Allergic contact dermatitis
RareModerate

Rare but possible in individuals with known peptide or cosmetic ingredient sensitivities. Perform a patch test on a small area of skin 24 hours before full-face application. Discontinue if rash, swelling, or severe itching develops.

Dryness or tightness
UncommonMild

May occur in very dry skin types. Ensure adequate moisturizer is applied after Matrixyl. Consider reducing application frequency if dryness persists.

Dosing Reference

ParameterValue
Dose range2-5 %
Frequency1-2x daily
TimingMorning and/or evening skincare routine
RouteTopical

Topical application only. Matrixyl is typically incorporated into serums, creams, or moisturizers at 2–5% concentration. Start with 1x daily application and increase to 2x daily if well-tolerated. Results are cumulative and typically visible after 4–8 weeks of consistent use.

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2–8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

Molecular weight755.9 g/mol (palmitoyl pentapeptide)
SequenceKTTKS (with N-terminal palmitoyl modification)

Matrixyl (Palmitoyl Pentapeptide-4) mimics a fragment of collagen I and acts as a signaling molecule to dermal fibroblasts. When applied topically, it binds to cell surface receptors and triggers intracellular pathways that upregulate collagen I, collagen III, and fibronectin production. This increases dermal matrix density and improves skin firmness and elasticity.

Fibroblast Activation via Collagen Fragment Signaling

The pentapeptide sequence (KTTKS) is recognized by fibroblasts as a breakdown product of collagen, triggering a wound-healing-like response that increases collagen synthesis and deposition in the dermis.

Extracellular Matrix (ECM) Remodeling

Increased production of collagen I, collagen III, and fibronectin strengthens the dermal scaffold, reducing the appearance of fine lines and improving skin texture and firmness.

  • Matrixyl is a synthetic pentapeptide derived from collagen I sequence
  • The palmitoyl lipid modification enhances skin penetration and stability
  • Stimulates collagen and fibronectin production in dermal fibroblasts
  • Effects are cumulative and typically visible after 4–8 weeks of consistent use

Track your Matrixyl research

Free account. No credit card required.

Start Free

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Matrixyl is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.